Burning Rock Biotech Limited
BNR
$4.52
-$0.18-3.83%
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 79.33% | 37.47% | 26.17% | 26.17% | 28.57% |
| Total Depreciation and Amortization | -- | -- | 7.14% | 7.14% | -- |
| Total Amortization of Deferred Charges | -- | -- | -42.75% | -42.75% | -- |
| Total Other Non-Cash Items | -95.66% | 7.50% | 79.65% | 79.65% | 25.55% |
| Change in Net Operating Assets | -- | -- | -359.99% | -359.99% | -- |
| Cash from Operations | 35.39% | 66.13% | 76.72% | 76.72% | 66.92% |
| Capital Expenditure | -- | -- | 88.65% | 88.65% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -96.59% | -96.59% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.69% | 43.99% | -87.95% | -87.95% | 90.69% |
| Cash from Investing | 49.69% | 43.99% | 93.59% | 93.59% | 90.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 90.29% | 90.29% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -92.10% | -92.10% | -1,618.01% |
| Cash from Financing | 100.00% | -- | 81.35% | 81.35% | -1,523.68% |
| Foreign Exchange rate Adjustments | -188.78% | 101.03% | 45.56% | 45.56% | -106.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.53% | 66.80% | 76.12% | 76.12% | 34.39% |
